Senti Biosciences, Inc. - Common Stock (SNTI)

Senti Biosciences, Inc. is a biotechnology company focused on developing innovative cell and gene therapies using its proprietary platform to enhance the therapeutic potential of engineered cells

The company utilizes advanced synthetic biology techniques to create intelligent and programmable therapies designed to target specific diseases with greater precision. By harnessing the power of genetic engineering, Senti aims to address unmet medical needs, particularly in the areas of cancer and other serious conditions, ultimately improving patient outcomes through its cutting-edge research and development initiatives.